A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kishnani, Priya
  • Tarnopolsky, Mark
  • Sivakumar, Kumarswamy
  • Roberts, Mark
  • Byrne, Barry
  • Goker-Alpan, Ozlem
  • Guter, Karl
  • Pervaiz, Muhammad Ali
  • Dasouki, Majed
  • Mozaffar, Tasheen
  • Finanger, Erika
  • Johnson, Franklin
  • Boudes, Pol

publication date

  • February 2013